Език: EN EN
← Назад към резултатите
Активно (без набиране) NCT06350734

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

Заболявания: Stage 0a Bladder Cancer AJCC v8 Stage 0is Bladder Cancer AJCC v8 Stage I Bladder Cancer AJCC v8 Stage II Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8

Спонсор: Mayo Clinic

Налично на: БГ
Обобщение
This study evaluates the effect of bladder cancer treatment on quality of life.
Описание
PRIMARY OBJECTIVES: I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively. II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer. OUTLINE: This is an observational study. Patients complete surveys and also have their medical records reviewed on study.
Кой може да участва
Inclusion Criteria: * Have pathologically confirmed, clinically localized, bladder cancer * Be willing to complete a survey in English before starting definitive treatment (surgery or radiation); * Able to give consent. Exclusion Criteria: * Does not meet inclusion criteria
Интервенции
Non-Interventional Study
OTHER
Места на провеждане 3
САЩ (3)
Mayo Clinic in Florida
Jacksonville , Florida
Mayo Clinic in Rochester
Rochester , Minnesota
Mayo Clinic in Arizona
Scottsdale , Arizona
Технически детайли
Статус
Активно (без набиране)
Вид изследване
OBSERVATIONAL
Пол
Мъже и жени
Минимална възраст
18 Years
Здрави доброволци
Не
Начална дата
12.10.2018
Крайна дата
31.01.2029
Регистрационен номер
NCT06350734
Източник
clinicaltrials.gov
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.